Literature DB >> 18305158

Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells.

Myung Soo Cho1, Young-Eun Lee, Ji Young Kim, Seungsoo Chung, Yoon Hee Cho, Dae-Sung Kim, Sang-Moon Kang, Haksup Lee, Myung-Hwa Kim, Jeong-Hoon Kim, Joong Woo Leem, Sun Kyung Oh, Young Min Choi, Dong-Youn Hwang, Jin Woo Chang, Dong-Wook Kim.   

Abstract

We developed a method for the efficient generation of functional dopaminergic (DA) neurons from human embryonic stem cells (hESCs) on a large scale. The most unique feature of this method is the generation of homogeneous spherical neural masses (SNMs) from the hESC-derived neural precursors. These SNMs provide several advantages: (i) they can be passaged for a long time without losing their differentiation capability into DA neurons; (ii) they can be coaxed into DA neurons at much higher efficiency than that from previous reports (86% tyrosine hydroxylase-positive neurons/total neurons); (iii) the induction of DA neurons from SNMs only takes 14 days; and (iv) no feeder cells are required during differentiation. These advantages allowed us to obtain a large number of DA neurons within a short time period and minimized potential contamination of unwanted cells or pathogens coming from the feeder layer. The highly efficient differentiation may not only enhance the efficacy of the cell therapy but also reduce the potential tumor formation from the undifferentiated residual hESCs. In line with this effect, we have never observed any tumor formation from the transplanted animals used in our study. When grafted into a parkinsonian rat model, the hESC-derived DA neurons elicited clear behavioral recovery in three behavioral tests. In summary, our study paves the way for the large-scale generation of purer and functional DA neurons for future clinical applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305158      PMCID: PMC2265201          DOI: 10.1073/pnas.0712359105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Derivation and characterization of new human embryonic stem cell lines: SNUhES1, SNUhES2, and SNUhES3.

Authors:  Sun Kyung Oh; Hee Sun Kim; Hee Jin Ahn; Hye Won Seol; Yoon Young Kim; Yong Bin Park; Chul Jong Yoon; Dong-Wook Kim; Seok Hyun Kim; Shin Yong Moon
Journal:  Stem Cells       Date:  2005-02       Impact factor: 6.277

2.  Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix.

Authors:  Morio Ueno; Michiru Matsumura; Kiichi Watanabe; Takahiro Nakamura; Fumitaka Osakada; Masayo Takahashi; Hiroshi Kawasaki; Shigeru Kinoshita; Yoshiki Sasai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

3.  Large stem cell grafts could lead to erroneous interpretations of behavioral results?

Authors:  Nicolaj Strøyer Christophersen; Patrik Brundin
Journal:  Nat Med       Date:  2007-02       Impact factor: 53.440

4.  Dopamine neurons derived from embryonic stem cells efficiently induce behavioral recovery in a Parkinsonian rat model.

Authors:  Yoon Hee Cho; Dae-Sung Kim; Peter Geon Kim; Yong Sup Hwang; Myung Soo Cho; Shin Yong Moon; Dong-Wook Kim; Jin Woo Chang
Journal:  Biochem Biophys Res Commun       Date:  2006-01-05       Impact factor: 3.575

5.  Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Authors:  Neeta S Roy; Carine Cleren; Shashi K Singh; Lichuan Yang; M Flint Beal; Steven A Goldman
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

6.  Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.

Authors:  Kai-Christian Sonntag; Jan Pruszak; Takahito Yoshizaki; Joris van Arensbergen; Rosario Sanchez-Pernaute; Ole Isacson
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

7.  Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

Authors:  Yasushi Takagi; Jun Takahashi; Hidemoto Saiki; Asuka Morizane; Takuya Hayashi; Yo Kishi; Hitoshi Fukuda; Yo Okamoto; Masaomi Koyanagi; Makoto Ideguchi; Hideki Hayashi; Takayuki Imazato; Hiroshi Kawasaki; Hirofumi Suemori; Shigeki Omachi; Hidehiko Iida; Nobuyuki Itoh; Norio Nakatsuji; Yoshiki Sasai; Nobuo Hashimoto
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

8.  Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells.

Authors:  Dong-Wook Kim; Sangmi Chung; Mikyeong Hwang; Andrew Ferree; Hsing-Chen Tsai; Jae-Joon Park; Seungsoo Chung; Taick Sang Nam; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Stem Cells       Date:  2005-08-25       Impact factor: 6.277

9.  Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.

Authors:  Yiping Yan; Dali Yang; Ewa D Zarnowska; Zhongwei Du; Brian Werbel; Chuck Valliere; Robert A Pearce; James A Thomson; Su-Chun Zhang
Journal:  Stem Cells       Date:  2005 Jun-Jul       Impact factor: 6.277

10.  Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation.

Authors:  Anke Brederlau; Ana Sofia Correia; Sergey V Anisimov; Muna Elmi; Gesine Paul; Laurent Roybon; Asuka Morizane; Filip Bergquist; Ilse Riebe; Ulf Nannmark; Manolo Carta; Erik Hanse; Jun Takahashi; Yoshiki Sasai; Keiko Funa; Patrick Brundin; Peter S Eriksson; Jia-Yi Li
Journal:  Stem Cells       Date:  2006-03-23       Impact factor: 6.277

View more
  98 in total

1.  Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain.

Authors:  Vladimer Darsalia; Susan J Allison; Carlo Cusulin; Emanuela Monni; Daniela Kuzdas; Therése Kallur; Olle Lindvall; Zaal Kokaia
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-09       Impact factor: 6.200

Review 2.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 3.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

4.  Dopaminergic neurons for Parkinson's therapy.

Authors:  Olle Lindvall
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

Review 5.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 6.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

Review 7.  Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons.

Authors:  Aaron B Bradford; Patrick M McNutt
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

Review 8.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

9.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 10.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.